Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;35(8):1988-2008.
doi: 10.1111/jocs.14808. Epub 2020 Jul 11.

Cardiac manifestations in COVID-19 patients-A systematic review

Ahmed M A Shafi  1 , Safwan A Shaikh  2 , Manasi M Shirke  2 , Sashini Iddawela  3 , Amer Harky  4   5
Affiliations

Cardiac manifestations in COVID-19 patients-A systematic review

Ahmed M A Shafi et al. J Card Surg. 2020 Aug.

Abstract

Objectives: The coronavirus disease-2019 (COVID-19) pandemic has resulted in the worst global pandemic of our generation, affecting 215 countries with nearly 5.5 million cases. The association between COVID-19 and the cardiovascular system has been well described. We sought to systematically review the current published literature on the different cardiac manifestations and the use of cardiac-specific biomarkers in terms of their prognostic value in determining clinical outcomes and correlation to disease severity.

Methods: A systematic literature review across PubMed, Cochrane database, Embase, Google Scholar, and Ovid was performed according to PRISMA guidelines to identify relevant articles that discussed risk factors for cardiovascular manifestations, cardiac manifestations in COVID-19 patients, and cardiac-specific biomarkers with their clinical implications on COVID-19.

Results: Sixty-one relevant articles were identified which described risk factors for cardiovascular manifestations, cardiac manifestations (including heart failure, cardiogenic shock, arrhythmia, and myocarditis among others) and cardiac-specific biomarkers (including CK-MB, CK, myoglobin, troponin, and NT-proBNP). Cardiovascular risk factors can play a crucial role in identifying patients vulnerable to developing cardiovascular manifestations of COVID-19 and thus help to save lives. A wide array of cardiac manifestations is associated with the interaction between COVID-19 and the cardiovascular system. Cardiac-specific biomarkers provide a useful prognostic tool in helping identify patients with the severe disease early and allowing for escalation of treatment in a timely fashion.

Conclusion: COVID-19 is an evolving pandemic with predominate respiratory manifestations, however, due to the interaction with the cardiovascular system; cardiac manifestations/complications feature heavily in this disease, with cardiac biomarkers providing important prognostic information.

Keywords: COVID-19; SARS-CoV-2; cardiac biomarkers; cardiac manifestations; cardiovascular risk factors; clinical presentations.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

Figures

Figure 1
Figure 1
PRISMA flow diagram
See this image and copyright information in PMC

References

    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497‐506. - PMC - PubMed
    1. Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID‐19 and Multiorgan Response. Current Problems in Cardiology. 2020;45(8):100618 10.1016/j.cpcardiol.2020.100618 - DOI - PMC - PubMed
    1. Mohamed Abdel Shafi A, Hewage S, Harky A. The impact of COVID‐19 on the provision of cardiac surgical services. J Card Surg. 202035(6):1295–1297. - PMC - PubMed
    1. Madjid M, Miller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy‐confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J. 2007;28:1205‐1210. - PMC - PubMed
    1. Kwong JC, Schwartz KL, Campitelli MA. Acute myocardial infarction after laboratory‐confirmed influenza infection. N Engl J Med. 2018;378:2540‐2541. - PubMed

Publication types